The result is a bioavailability profile sufficient to drive clinically meaningful weight loss, something the scientific community long considered impossible for peptide-based GLP-1s
A single molecular entity simultaneously activates both the GLP-1 receptor and the amylin receptor (calcitonin receptor complex), combining two complementary satiety and metabolic pathways: GLP-1 receptor activation : Glucose-dependent insulin secretion, glucagon suppression, delayed gastric emptying, and central appetite reduction through hypothalamic signaling Amylin receptor activation : Additional satiety signaling through the area postrema, complementary gastric emptying delay, and glucagon suppression through a distinct mechanism The unimolecular design means both receptor activations occur at a fixed ratio determined by the molecular structure
In some cases, prescription medications or further testing may be necessary
4% GHK-Cu Face and Neck Cream by Neurogan Health We found that the best way to get the benefits of copper peptides is with a daily routine, which is why we've made this 4% copper peptide face cream for daily use
Cesarone MR, Belcaro G, Nicolaides AN, et al